1. Home
  2. IVVD vs GCTS Comparison

IVVD vs GCTS Comparison

Compare IVVD & GCTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • GCTS
  • Stock Information
  • Founded
  • IVVD 2020
  • GCTS 1998
  • Country
  • IVVD United States
  • GCTS United States
  • Employees
  • IVVD N/A
  • GCTS N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • GCTS Blank Checks
  • Sector
  • IVVD Health Care
  • GCTS Finance
  • Exchange
  • IVVD Nasdaq
  • GCTS Nasdaq
  • Market Cap
  • IVVD 63.4M
  • GCTS 73.7M
  • IPO Year
  • IVVD 2021
  • GCTS N/A
  • Fundamental
  • Price
  • IVVD $1.43
  • GCTS $1.52
  • Analyst Decision
  • IVVD Strong Buy
  • GCTS Strong Buy
  • Analyst Count
  • IVVD 4
  • GCTS 1
  • Target Price
  • IVVD $3.64
  • GCTS $5.00
  • AVG Volume (30 Days)
  • IVVD 15.0M
  • GCTS 269.9K
  • Earning Date
  • IVVD 11-13-2025
  • GCTS 11-13-2025
  • Dividend Yield
  • IVVD N/A
  • GCTS N/A
  • EPS Growth
  • IVVD N/A
  • GCTS N/A
  • EPS
  • IVVD N/A
  • GCTS N/A
  • Revenue
  • IVVD $46,210,000.00
  • GCTS $6,073,000.00
  • Revenue This Year
  • IVVD $385.94
  • GCTS $133.55
  • Revenue Next Year
  • IVVD $62.62
  • GCTS $347.37
  • P/E Ratio
  • IVVD N/A
  • GCTS N/A
  • Revenue Growth
  • IVVD 1941.08
  • GCTS N/A
  • 52 Week Low
  • IVVD $0.35
  • GCTS $0.90
  • 52 Week High
  • IVVD $2.74
  • GCTS $3.45
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 72.86
  • GCTS 63.54
  • Support Level
  • IVVD $0.96
  • GCTS $1.26
  • Resistance Level
  • IVVD $1.45
  • GCTS $1.59
  • Average True Range (ATR)
  • IVVD 0.19
  • GCTS 0.07
  • MACD
  • IVVD 0.05
  • GCTS 0.03
  • Stochastic Oscillator
  • IVVD 97.86
  • GCTS 79.73

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About GCTS GCT Semiconductor Holding Inc. Common Stock

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

Share on Social Networks: